Health

Bioanalytical Systems

$12.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.19 (-8.82%) Today
$0.00 (0.00%) As of 9:43 AM UTC after-hours

Why Robinhood?

You can buy or sell BASI and other stocks, options, and ETFs commission-free!

About BASI

Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN. The listed name for BASI is Bioanalytical Systems, Inc. Common Stock.

CEO
Robert Leasure
Employees
421
Headquarters
West Lafayette, Indiana
Founded
1974
Market Cap
140.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
133.52K
High Today
$13.40
Low Today
$12.23
Open Price
$13.28
Volume
132.23K
52 Week High
$15.87
52 Week Low
$3.05

Collections

BASI Earnings

-$0.16
-$0.10
-$0.03
$0.03
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Feb 9, After Hours

You May Also Like

UCYB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure